Blood Coagulation-Inspired Fibrin Hydrogel for Portable Detection of Thrombin Based on Personal Glucometer.


Journal

Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191

Informations de publication

Date de publication:
16 May 2024
Historique:
received: 15 04 2024
revised: 09 05 2024
accepted: 14 05 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: epublish

Résumé

As one of the biomarkers of coagulation system-related diseases, the detection of thrombin is of practical importance. Thus, this study developed a portable biosensor based on a personal glucometer for rapid detection of thrombin activity. Fibrinogen was used for the detection of thrombin, and the assay principle was inspired by the blood coagulation process, where thrombin hydrolyzes fibrinogen to produce a fibrin hydrogel, and the amount of invertase encapsulated in the fibrin hydrogel fluctuates in accordance with the activity of thrombin in the sample solution. The quantitative assay is conducted by measuring the amount of unencapsulated invertase available to hydrolyze the substrate sucrose, and the signal readout is recorded using a personal glucometer. A linear detection range of 0-0.8 U/mL of thrombin with a limit of detection of 0.04 U/mL was obtained based on the personal glucometer sensing platform. The results of the selectivity and interference experiments showed that the developed personal glucometer sensing platform is highly selective and accurate for thrombin activity. Finally, the reliability of the portable glucometer method for rapid thrombin detection in serum samples was investigated by measuring the recovery rate, which ranged from 92.8% to 107.7%. In summary, the fibrin hydrogel sensing platform proposed in this study offers a portable and versatile means for detecting thrombin using a personal glucometer. This approach not only simplifies the detection process, but also eliminates the need for large instruments and skilled operators, and substantially reduces detection costs.

Identifiants

pubmed: 38785724
pii: bios14050250
doi: 10.3390/bios14050250
pii:
doi:

Substances chimiques

Thrombin EC 3.4.21.5
Fibrin 9001-31-4
Hydrogels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Chongqing Postdoctoral Science Foundation, China
ID : CSTB2022NSCQ-BHX0687
Organisme : Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau), China
ID : 2023MSXM006
Organisme : Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau), China
ID : 2024QNXM015
Organisme : Chongqing Shapingba Medical Scientific Research Project (Joint project of Chongqing Shapingba Health Commission and Science and Technology Bureau), China
ID : 2023SQKWLH037
Organisme : Chongqing Medical and Pharmaceutical College, China
ID : ygz2023117
Organisme : Chongqing Medical and Pharmaceutical College, China
ID : ygzrc2023102
Organisme : Science and Technology Research Program of Chongqing Municipal Education Commission, China
ID : KJQN202215131
Organisme : Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
ID : cstc2021jcyj-msxmX0353

Auteurs

Dan-Ni Yang (DN)

Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.

Shu-Yi Wu (SY)

Basic Medical College, Chongqing College of Traditional Chinese Medicine, Chongqing 402360, China.

Han-Yu Deng (HY)

Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.

Hao Zhang (H)

Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.

Shan Shi (S)

The Central Laboratory, The Affiliated Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.

Shan Geng (S)

The Central Laboratory, The Affiliated Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH